NCT Number: NCT06378346
Phase: PHASE2
Trial Summary: This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy) – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Illinois at Chicago
Acronym: GU-01
GU-01: Glycyrrhizin in Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives